Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2015

01.04.2015 | Gynecologic Oncology

Postoperative Time Course and Utility of Inflammatory Markers in Patients with Ovarian Peritoneal Carcinomatosis Treated with Neoadjuvant Chemotherapy, Cytoreductive Surgery, and HIPEC

verfasst von: F. J. Medina Fernández, MD, F. C. Muñoz-Casares, MD, PhD, A. Arjona-Sánchez, MD, PhD, A. Casado-Adam, MD, I. Gómez-Luque, MD, D. J. Garcilazo Arismendi, MD, H. Thoelecke, MD, S. Rufián Peña, MD, PhD, J. Briceño Delgado, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Inflammatory markers may help monitor postoperative evolution of surgical patients and detect complications. However, to date, the effect that neoadjuvant chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) may have in the postoperative kinetics of these parameters remains unknown.

Methods

Between July 2011 and June 2014, all patients who underwent neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC for ovarian peritoneal carcinomatosis were studied. Patients were divided into four groups: no complications, noninfective complication, and infective complications during the first and second postoperative weeks. Retrospectively, C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), white blood cell count, platelet-to-lymphocyte ratio, and prothrombin ratio were collected from postoperative days 1–14. Postoperative behavior of each parameter was carefully evaluated across groups.

Results

The study included 122 patients. Only CRP and NLR showed promising results. CRP presented a mean peak value at 48 h (186.1 mg/L), while NLR peaked at 24 h (10.21 mg/L). Both parameters rose with infective complications. Statistically significant differences were found at several time points compared with uncomplicated patients. A simple test comparing the peak value of CRP with the value when an infective complication was suspected accurately diagnosed these complications with sensitivity of 81 %, specificity of 91 %, and negative and positive predictive value of 93.1 and 76 %, respectively. This comparison presented lower diagnostic performance when NLR was used.

Conclusions

Both CRP and NLR are useful in monitoring postoperative evolution in these patients; however, only CRP is useful for detecting infective complications.
Literatur
1.
Zurück zum Zitat Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S161–92.CrossRefPubMed Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S161–92.CrossRefPubMed
3.
Zurück zum Zitat Munoz-Casares FC, Rufian S, Arjona-Sanchez A, et al. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study. Cancer Chemother Pharmacol. 2011;68:267–74.CrossRefPubMed Munoz-Casares FC, Rufian S, Arjona-Sanchez A, et al. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study. Cancer Chemother Pharmacol. 2011;68:267–74.CrossRefPubMed
4.
Zurück zum Zitat Munoz-Casares FC, Rufian S, Rubio MJ, et al. The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer. Clin Transl Oncol. 2009;11:753–9.CrossRefPubMed Munoz-Casares FC, Rufian S, Rubio MJ, et al. The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer. Clin Transl Oncol. 2009;11:753–9.CrossRefPubMed
5.
Zurück zum Zitat Munoz-Casares FC, Rufian S, Rubio MJ, et al. Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals. Clin Transl Oncol. 2007;9:652–62.CrossRefPubMed Munoz-Casares FC, Rufian S, Rubio MJ, et al. Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals. Clin Transl Oncol. 2007;9:652–62.CrossRefPubMed
6.
Zurück zum Zitat Helm CW, Richard SD, Pan J, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010;20:61–9.CrossRefPubMed Helm CW, Richard SD, Pan J, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010;20:61–9.CrossRefPubMed
7.
Zurück zum Zitat Yoon SI, Lim SS, Rha JD, et al. The C-reactive protein (CRP) in patients with long bone fractures and after arthroplasty. Int Orthop. 1993;17:198–201.CrossRefPubMed Yoon SI, Lim SS, Rha JD, et al. The C-reactive protein (CRP) in patients with long bone fractures and after arthroplasty. Int Orthop. 1993;17:198–201.CrossRefPubMed
8.
Zurück zum Zitat Dupont C, Rodenbach J, Flachaire E. The value of C-reactive protein for postoperative monitoring of lower limb arthroplasty. Ann Readapt Med Phys. 2008;51:348–57.CrossRefPubMed Dupont C, Rodenbach J, Flachaire E. The value of C-reactive protein for postoperative monitoring of lower limb arthroplasty. Ann Readapt Med Phys. 2008;51:348–57.CrossRefPubMed
9.
Zurück zum Zitat Mok JM, Pekmezci M, Piper SL, et al. Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early postoperative infectious complications. Spine. 2008;33:415–21.CrossRefPubMed Mok JM, Pekmezci M, Piper SL, et al. Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early postoperative infectious complications. Spine. 2008;33:415–21.CrossRefPubMed
10.
Zurück zum Zitat Kang BU, Lee SH, Ahn Y, Choi WC, Choi YG. Surgical site infection in spinal surgery: detection and management based on serial C-reactive protein measurements. J Neurosurg Spine. 2010;13:158–64.CrossRefPubMed Kang BU, Lee SH, Ahn Y, Choi WC, Choi YG. Surgical site infection in spinal surgery: detection and management based on serial C-reactive protein measurements. J Neurosurg Spine. 2010;13:158–64.CrossRefPubMed
11.
Zurück zum Zitat Neumaier M, Scherer MA. C-reactive protein levels for early detection of postoperative infection after fracture surgery in 787 patients. Acta Orthop. 2008;79:428–32.CrossRefPubMed Neumaier M, Scherer MA. C-reactive protein levels for early detection of postoperative infection after fracture surgery in 787 patients. Acta Orthop. 2008;79:428–32.CrossRefPubMed
12.
Zurück zum Zitat Ortega-Deballon P, Radais F, Facy O, et al. C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg. 2010;34:808–14.CrossRefPubMedCentralPubMed Ortega-Deballon P, Radais F, Facy O, et al. C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg. 2010;34:808–14.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Almeida AB, Faria G, Moreira H, Pinto-de-Sousa J, Correia-da-Silva P, Maia JC. Elevated serum C-reactive protein as a predictive factor for anastomotic leakage in colorectal surgery. Int J Surg. 2012;10:87–91.CrossRefPubMed Almeida AB, Faria G, Moreira H, Pinto-de-Sousa J, Correia-da-Silva P, Maia JC. Elevated serum C-reactive protein as a predictive factor for anastomotic leakage in colorectal surgery. Int J Surg. 2012;10:87–91.CrossRefPubMed
14.
Zurück zum Zitat Lagoutte N, Facy O, Ravoire A, et al. C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery: pilot study in 100 patients. J Visc Surg. 2012;149:e345–9.CrossRefPubMed Lagoutte N, Facy O, Ravoire A, et al. C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery: pilot study in 100 patients. J Visc Surg. 2012;149:e345–9.CrossRefPubMed
15.
Zurück zum Zitat Oberhofer D, Juras J, Pavicic AM, Rancic Zuric I, Rumenjak V. Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. Croat Med J. 2012;53:612–9.CrossRefPubMedCentralPubMed Oberhofer D, Juras J, Pavicic AM, Rancic Zuric I, Rumenjak V. Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. Croat Med J. 2012;53:612–9.CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Platt JJ, Ramanathan ML, Crosbie RA, et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol. 2012;19:4168–77.CrossRefPubMed Platt JJ, Ramanathan ML, Crosbie RA, et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol. 2012;19:4168–77.CrossRefPubMed
17.
Zurück zum Zitat Garcia-Granero A, Frasson M, Flor-Lorente B, et al. Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study. Dis Colon Rectum. 2013;56:475–83.CrossRefPubMed Garcia-Granero A, Frasson M, Flor-Lorente B, et al. Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study. Dis Colon Rectum. 2013;56:475–83.CrossRefPubMed
18.
Zurück zum Zitat Guirao X, Juvany M, Franch G, Navines J, Amador S, Badia JM. Value of C-reactive protein in the assessment of organ-space surgical site infections after elective open and laparoscopic colorectal surgery. Surg Infect. 2013;14:209–15.CrossRef Guirao X, Juvany M, Franch G, Navines J, Amador S, Badia JM. Value of C-reactive protein in the assessment of organ-space surgical site infections after elective open and laparoscopic colorectal surgery. Surg Infect. 2013;14:209–15.CrossRef
19.
Zurück zum Zitat Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC. Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg. 2011;35:1017–25.CrossRefPubMed Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC. Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications. World J Surg. 2011;35:1017–25.CrossRefPubMed
20.
Zurück zum Zitat Warschkow R, Tarantino I, Ukegjini K, et al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery. Langenbecks Arch Surg. 2012;397:727–36.CrossRefPubMed Warschkow R, Tarantino I, Ukegjini K, et al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery. Langenbecks Arch Surg. 2012;397:727–36.CrossRefPubMed
21.
Zurück zum Zitat Dominguez-Comesana E, Lopez-Gomez V, Estevez-Fernandez SM, et al. Procalcitonin and C-reactive protein as early indicators of postoperative intra-abdominal infection after surgery for gastrointestinal cancer. Cir Esp. 2014;92:240–6.CrossRefPubMed Dominguez-Comesana E, Lopez-Gomez V, Estevez-Fernandez SM, et al. Procalcitonin and C-reactive protein as early indicators of postoperative intra-abdominal infection after surgery for gastrointestinal cancer. Cir Esp. 2014;92:240–6.CrossRefPubMed
22.
Zurück zum Zitat Warschkow R, Tarantino I, Folie P, et al. C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg. 2012;16:1128–35.CrossRefPubMed Warschkow R, Tarantino I, Folie P, et al. C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg. 2012;16:1128–35.CrossRefPubMed
23.
Zurück zum Zitat Albanopoulos K, Alevizos L, Natoudi M, et al. C-reactive protein, white blood cells, and neutrophils as early predictors of postoperative complications in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc. 2013;27:864–71.CrossRefPubMed Albanopoulos K, Alevizos L, Natoudi M, et al. C-reactive protein, white blood cells, and neutrophils as early predictors of postoperative complications in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc. 2013;27:864–71.CrossRefPubMed
24.
Zurück zum Zitat Romain B, Chemaly R, Meyer N, et al. Diagnostic markers of postoperative morbidity after laparoscopic Roux-en-Y gastric bypass for obesity. Langenbecks Arch Surg. 2014;399:503–8.CrossRefPubMed Romain B, Chemaly R, Meyer N, et al. Diagnostic markers of postoperative morbidity after laparoscopic Roux-en-Y gastric bypass for obesity. Langenbecks Arch Surg. 2014;399:503–8.CrossRefPubMed
25.
Zurück zum Zitat Ramanathan ML, Mackay G, Platt J, Horgan PG, McMillan DC. Impact of day 2 C-reactive protein on day 3 and 4 thresholds associated with infective complications following curative surgery for colorectal cancer. World J Surg. 2013;37:2705–10.CrossRefPubMed Ramanathan ML, Mackay G, Platt J, Horgan PG, McMillan DC. Impact of day 2 C-reactive protein on day 3 and 4 thresholds associated with infective complications following curative surgery for colorectal cancer. World J Surg. 2013;37:2705–10.CrossRefPubMed
26.
Zurück zum Zitat Terradas R, Grau S, Blanch J, et al. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS ONE. 2012;7:e42860.CrossRefPubMedCentralPubMed Terradas R, Grau S, Blanch J, et al. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS ONE. 2012;7:e42860.CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat de Jager CP, Wever PC, Gemen EF, et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS ONE. 2012;7:e46561.CrossRefPubMedCentralPubMed de Jager CP, Wever PC, Gemen EF, et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS ONE. 2012;7:e46561.CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Koyama K, Madoiwa S, Tanaka S, et al. Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis. J Crit Care. 2013;28:556–63.CrossRefPubMed Koyama K, Madoiwa S, Tanaka S, et al. Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis. J Crit Care. 2013;28:556–63.CrossRefPubMed
29.
Zurück zum Zitat Hoppensteadt D, Tsuruta K, Cunanan J, et al. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin. Clin Appl Thromb Hemost. 2014;20:129–35.CrossRefPubMed Hoppensteadt D, Tsuruta K, Cunanan J, et al. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin. Clin Appl Thromb Hemost. 2014;20:129–35.CrossRefPubMed
30.
Zurück zum Zitat Turak O, Ozcan F, Isleyen A, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol. 2013;29:1672–8.CrossRefPubMed Turak O, Ozcan F, Isleyen A, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol. 2013;29:1672–8.CrossRefPubMed
31.
Zurück zum Zitat Kahramanca S, Kaya O, Ozgehan G, et al. Are neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as effective as Fournier’s gangrene severity index for predicting the number of debridements in Fourner’s gangrene? Ulus Travma Acil Cerrahi Derg. 2014;20:107–12.CrossRefPubMed Kahramanca S, Kaya O, Ozgehan G, et al. Are neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as effective as Fournier’s gangrene severity index for predicting the number of debridements in Fourner’s gangrene? Ulus Travma Acil Cerrahi Derg. 2014;20:107–12.CrossRefPubMed
32.
Zurück zum Zitat Loonen AJ, de Jager CP, Tosserams J, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One. 2014;9:e87315.CrossRefPubMedCentralPubMed Loonen AJ, de Jager CP, Tosserams J, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One. 2014;9:e87315.CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil–lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14:R192.CrossRefPubMedCentralPubMed de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil–lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14:R192.CrossRefPubMedCentralPubMed
34.
36.
Zurück zum Zitat Barbic J, Ivic D, Alkhamis T, et al. Kinetics of changes in serum concentrations of procalcitonin, interleukin-6, and C-reactive protein after elective abdominal surgery. Can it be used to detect postoperative complications? Coll Antropol. 2013;37:195–201.PubMed Barbic J, Ivic D, Alkhamis T, et al. Kinetics of changes in serum concentrations of procalcitonin, interleukin-6, and C-reactive protein after elective abdominal surgery. Can it be used to detect postoperative complications? Coll Antropol. 2013;37:195–201.PubMed
37.
Zurück zum Zitat Scepanovic MS, Kovacevic B, Cijan V, et al. C-reactive protein as an early predictor for anastomotic leakage in elective abdominal surgery. Tech Coloproctol. 2013;17:541–7.CrossRefPubMed Scepanovic MS, Kovacevic B, Cijan V, et al. C-reactive protein as an early predictor for anastomotic leakage in elective abdominal surgery. Tech Coloproctol. 2013;17:541–7.CrossRefPubMed
38.
Zurück zum Zitat Nason GJ, Barry BD, Obinwa O, McMacken E, Rajaretnam NS, Neary PC. Early rise in C-reactive protein is a marker for infective complications in laparoscopic colorectal surgery. Surg Laparosc Endosc Percutan Tech. 2014;24:57–61.CrossRefPubMed Nason GJ, Barry BD, Obinwa O, McMacken E, Rajaretnam NS, Neary PC. Early rise in C-reactive protein is a marker for infective complications in laparoscopic colorectal surgery. Surg Laparosc Endosc Percutan Tech. 2014;24:57–61.CrossRefPubMed
39.
Zurück zum Zitat Warschkow R, Beutner U, Steffen T, et al. Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients. Ann Surg. 2012;256:245–50.CrossRefPubMed Warschkow R, Beutner U, Steffen T, et al. Safe and early discharge after colorectal surgery due to C-reactive protein: a diagnostic meta-analysis of 1832 patients. Ann Surg. 2012;256:245–50.CrossRefPubMed
40.
Zurück zum Zitat Montagnana M, Minicozzi AM, Salvagno GL, et al. Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab. 2009;55:187–92.PubMed Montagnana M, Minicozzi AM, Salvagno GL, et al. Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab. 2009;55:187–92.PubMed
41.
Zurück zum Zitat Ruiz-Iban MA, Diaz Heredia J, Cebreiro Martinez Val I, et al. Evolution of C-reactive protein values in the first month after anterior cruciate ligament reconstruction: reference values. Knee Surg Sports Traumatol Arthrosc. 2013 [Epub ahead of print]. Ruiz-Iban MA, Diaz Heredia J, Cebreiro Martinez Val I, et al. Evolution of C-reactive protein values in the first month after anterior cruciate ligament reconstruction: reference values. Knee Surg Sports Traumatol Arthrosc. 2013 [Epub ahead of print].
Metadaten
Titel
Postoperative Time Course and Utility of Inflammatory Markers in Patients with Ovarian Peritoneal Carcinomatosis Treated with Neoadjuvant Chemotherapy, Cytoreductive Surgery, and HIPEC
verfasst von
F. J. Medina Fernández, MD
F. C. Muñoz-Casares, MD, PhD
A. Arjona-Sánchez, MD, PhD
A. Casado-Adam, MD
I. Gómez-Luque, MD
D. J. Garcilazo Arismendi, MD
H. Thoelecke, MD
S. Rufián Peña, MD, PhD
J. Briceño Delgado, MD, PhD
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4096-5

Weitere Artikel der Ausgabe 4/2015

Annals of Surgical Oncology 4/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.